Boston Matthews, an extrusion machinery manufacturer, is pleased to announce the completion and shipping of multiple extruders to be used in the direct treatment of Covid-19.
Due to the sensitive nature of the machinery, its application and the customer, Boston Matthews is unable to divulge the specification of the extruders or name the customer.
A world-renowned manufacturer of medical devices will use the extruders to produce vital components that will be used in intensive care units and other respiratory care environments of hospitals in more than 120 countries around the globe.
Simon Brookes, Managing Director at Boston Matthews, said: “The order was placed when the majority of the world was either in lockdown or about to enter lockdown which was a very strange and uncertain time which I think everyone will empathise with. However, it was of vital importance to the customer that we were able to maintain our production levels and commit to fulfilling this extremely sensitive order on time.
“Knowing how important this order was especially in the middle of a pandemic it was also of vital importance we maintained production for our existing machine order obligations. We therefore undertook a massive internal planning initiative involving all aspects of the supply chain, production levels and personnel availability so that we could accommodate this order.
“As a result, a select team was chosen specifically to handle this new order from start to finish and I am very pleased to say they performed professionally and diligently throughout and the entire project was completed ahead of schedule.”